Radioembolization with 90Y-Labeled Glass Microspheres: Analytical Methods for Patient-Personalized Voxel-Based Dosimetry

被引:1
|
作者
Ferreira, P. [1 ,3 ]
Parafita, R. [2 ]
Girao, P. S. [3 ]
Correia, P. L. [3 ]
Costa, D. C. [1 ]
机构
[1] Champalimaud Fdn, Champalimaud Ctr Unknown, Nucl Med Radiopharmacol Dept, Lisbon, Portugal
[2] Champalimaud Fdn, Mercurius Hlth, Nucl Med Radiopharmacol Dept, Champalimaud Ctr Unknown, Lisbon, Portugal
[3] Univ Lisbon, Inst Super Tecn, Inst Telecomunicacoes, Lisbon, Portugal
来源
VIPIMAGE 2017 | 2018年 / 27卷
关键词
QUANTITATIVE-EVALUATION; DOSE DISTRIBUTIONS; S VALUES; THERAPY;
D O I
10.1007/978-3-319-68195-5_20
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Radioembolization (RE) is a radiation treatment based on intra-arterial injection of Yttrium-90 (Y-90) labeled microspheres, recognized as an efficient clinical practice for liver neoplasms either primary or metastatic. As a current practice, the RE procedure follows the guidelines of the microsphere manufacturers. At the Champalimaud Centre for the Unknown (CCU), Champalimaud Foundation (CF), we have been using Y-90-labeled glass microspheres (Therasphere (R)) in our patients referred for hepatic RE treatments. Following the Therasphere (R) guidelines, the calculation of Y-90 activity to be injected through the hepatic artery, is based on the formalism of the MIRD (Medical Internal Radiation Dose) committee of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). The calculation model is based on the prescribed absorbed dose and the liver volume (total, lobe or segment), not considering any patient-specific characteristics that can influence the microspheres deposition. Accurate absorbed dose calculation in the liver is crucial for treatment planning and establishing the dose-effect correlation between tumor control and normal tissue complications. Therefore, our research group has been developing patient-personalized voxel-based dosimetry analysis of Single Photon Emission Computer Tomography (SPECT) images obtained from the patient injected with Technetium-99 m Macroaggregated Albumin (99mTc-MAA) in a pre-treatment phase. The use of Tc-99m-MAA as a Y-90 microsphere surrogate is one of the biggest challenges in hepatic RE due to the intrinsic differences between particles (MAA vs glass microspheres) and consequent distribution in the liver parenchyma. Therefore, we capture post-treatment Y-90 Positron Emission Tomography PET images to investigate the predictive power of the pre-treatment MAA dose distributions in comparison with the post-treatment Y-90 dose maps. Two analytical methods have been used in our analysis: the gamma-index (gamma-index) test, as a numerical measure of the agreement between two image
引用
收藏
页码:185 / 191
页数:7
相关论文
共 50 条
  • [1] Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with 90Y Glass Microspheres
    Watanabe, Masao
    Grafe, Hong
    Theysohn, Jens
    Schaarschmidt, Benedikt
    Ludwig, Johannes
    Jochheim, Leonie
    Jeschke, Matthias
    Schmidt, Hartmut
    Fendler, Wolfgang P.
    Moraitis, Alexandros
    Herrmann, Ken
    Pomykala, Kelsey L.
    Weber, Manuel
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (07) : 1102 - 1108
  • [2] Voxel-based Dosimetry in the Liver: Yttrium-90 Microspheres Radioembolization After SBRT
    Ferreira, P.
    Oliveira, F. P. M.
    Parafita, R.
    Girao, P. S.
    Correia, P. L.
    Pares, O.
    Costa, D. C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S234 - S234
  • [3] Voxel-based dosimetry with integrated Y-90 PET/MRI and prediction of response of primary and metastatic liver tumors to radioembolization with Y-90 glass microspheres
    Demir, Burak
    Soydal, Cigdem
    Kucuk, Nuriye Ozlem
    Celebioglu, Emre Can
    Bilgic, Mehmet Sadik
    Oz, Digdem Kuru
    Elhan, Atilla Halil
    Kir, Kemal Metin
    ANNALS OF NUCLEAR MEDICINE, 2025, 39 (01) : 31 - 46
  • [4] Personalized Dosimetry planning in Radioembolization with 90Y-microspheres: Methodological Considerations
    Moran, V.
    Prieto, E.
    Zubiria, A.
    Sancho, L.
    Rodriguez-Fraile, M.
    Barbes, B.
    Ramos, L.
    Marti-Climent, J. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S410 - S410
  • [5] The Importance of SPECT Imaging Attenuation Correction During Treatment Planning for 90Y-labeled Glass Microspheres Liver Radioembolization
    Demino, Laura
    Ferreira, Paulo
    Oliveira, Francisco P. M.
    Costa, Durval C.
    VIPIMAGE 2017, 2018, 27 : 266 - 274
  • [6] Radioembolization of hepatocarcinoma with 90Y glass microspheres: voxel dosimetry or mean dose approach to predict clinical outcomes?
    Romano, C.
    Mazzaglia, S.
    De Nile, M. C.
    Bhoori, S.
    Gabutti, A.
    Maffi, G.
    Spreafico, C.
    Marchiano, A.
    Mazzaferro, V.
    Maccauro, M.
    Seregni, E.
    Chiesa, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S109 - S109
  • [7] Prediction of left lobe hypertrophy with voxel-based dosimetry using integrated Y-90 PET/MRI after radioembolization of liver tumors with Y-90 microspheres
    Demir, Burak
    Soydal, Cigdem
    Celebioglu, Emre Can
    Bilgic, Mehmet Sadik
    Kuru Oz, Digdem
    Kir, Kemal Metin
    Kucuk, Nuriye Ozlem
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, : 1695 - 1707
  • [8] Radioembolization with 90Y-labeled microspheres: Post-therapeutic therapy validation with Bremsstrahlung-SPECT
    Grosser, Oliver S.
    Nultsch, Madeleine
    Laatz, Kathleen
    Ulrich, Gerd
    Seidensticker, Ricarda
    Pethe, Annette
    Dudeck, Oliver
    Pech, Maciej
    Knoop, Bernd O.
    Ricke, Jens
    Amthauer, Holger
    Geworski, Lilli
    ZEITSCHRIFT FUR MEDIZINISCHE PHYSIK, 2011, 21 (04): : 274 - 280
  • [9] Voxel-based personalized dosimetry in Y90 microsphere radioembolization comparison between Monte Carlo simulation method and conventional partition model ocr
    Lee, Sin-Di
    Lin, Hsin-Hon
    Peng, Nan-Jing
    Chou, Ming-Chung
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [10] Hepatocellular Carcinoma Tumor Dose Response After 90Y-radioembolization With Glass Microspheres Using 90Y-SPECT/CT-Based Voxel Dosimetry
    Kappadath, S. Cheenu
    Mikell, Justin
    Balagopal, Anjali
    Baladandayuthapani, Veera
    Kaseb, Ahmed
    Mahvash, Armeen
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (02): : 451 - 461